Clinical trial
Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant
NCT05416190 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Injectable Anticoagulants on Research for a Circulating Lupus-type Anticoagulant
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 2, 2022
- Completion date
- May 21, 2024
- Enrollment
- 188 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulant drugs, antiphospholipid syndrome